Abstract
AIM: To investigate the effect of tetramethylpyrazine on hepatic/renal ischemia and reperfusion injury in rats.
METHODS: Hepatic/renal function, histopathological changes, and hepatic/renal P-selectin expression were studied with biochemical measurement and immunohistochemistry in hepatic/renal ischemia and reperfusion injury in rat models.
RESULTS: Hepatic/renal insufficiency and histopathological damage were much less in the tetramethylpyrazine-treated group than those in the saline-treated groups. Hepatic/renal P-selectin expression was down regulated in the tetramethylpyrazine-treated group.
CONCLUSION: P-selectin might mediate neutrophil infiltration and contribute to hepatic/renal ischemia and reperfusion injury. Tetramethylpyrazine might prevent hepatic/renal damage induced by ischemia and reperfusion injury through inhibition of P-selectin.
INTRODUCTION
Hepatic/renal ischemia-reperfusion injury is common clinically. Up to now, there has been no effective treatment for this pathological injury. Cell adhesion molecules have been found to play an important role in hepatic/renal ischemia-reperfusion injury by mediating interactions of polymorphonuclear neutrophils with endothelium. P-seletin monoclonal antibody has been demonstrated to prevent effectively reperfusion-induced hepatic/renal tissue damage[1-23]. Tetramethylpyrazine (TMP), a traditional Chinese herb, has been widely used especially in the treatment of patients with cerebral and cardiac ischemic diseases in China. Experimental study has found that TMP could protect vascular endothelial cells, and inhibit respiratory explosion and free radicals of polymorphonuclear neutrophils[24-28]. In the present study, we investigated the effect of TMP and P-selectin on hepatic ischemia and reperfusion injury in rats.
MATERIALS AND METHODS
Animal model
Ninety male Wistar rats (Shanghai Experimental Animal Center of Chinese Academy of Sciences), weighing 200 ± 10 g, were given free access to food and water for three days before the experiments. The rats were anesthetized with 2.5% sodium pentobarbital intraperitoneally, and randomly divided into 2 groups. In one group of rats, the ligament linking liver, diaphragm and abdominal wall were separated, the portal vein and liver artery that drain blood to left hepatic lobe were freed by blunt dissection and then blocked with a microvascular clamp for 60 min, then the clamp was removed, and reperfusion was performed. While in the other group, the left renal artery was freed, and blocked with a microvascular clamp for 60 min, then the clamp was removed and reperfusion was performed, simultaneously, the right kidney was cut off. The two groups of rats were randomly divided into TMP-treated group (n = 20) and non-treated group (n = 20). They were divided into subgroups according to the indicated time 1, 3, 6, 24 h after reperfusion. TMP or saline was intravenously injected five minutes before the reperfusion. A sham-operated group (n = 5, anesthesia and opening celiac cavity, no blocking of hepatic or renal blood flow) served as control.
Collection and measurement methods of specimens
Blood and hepatic and renal tissues were harvested at the indicated time. Serum levels of aspartate aminotransferase (AST) and alanine aminotransferase (ALT), and blood urea nitrogen (BUN) and creatinine (Cr) were measured with a 747 automatic analyzor (Hitachi Boehringer Mannhein, Mannhein, Germany). Hepatic and renal tissue samples were fixed in 10% formalin and embedded in paraffin. 5 μm thick sections were cut into and stained with hematoxylin and eosin for light microscope examination. Expression of P-selectin in hepatic/renal tissue was detected by immunohistochemistry method with a labeled streptavidin biotin (LSAB) kit (Fujian Maixin Biotechnology Co., products of Biotechnology Co. CA, USA).
Statistical analysis
Data were presented as ¯x ± s, and Student's t test was used to determine changes between different groups. P < 0.05 was considered significant.
RESULTS
Histopathologic evaluation
One hour after reperfusion, visual observation revealed that the left hepatic lobe was more swollen than the right lobe, and was dark in color. Under the light microscope, interstitial congestion and infiltration of inflammatory cells were observed. One hour after reperfusion, the renal cortex was macroscopically pale, the renal medulla displayed blood stagnation and was dark in color. Under the light microscope, edema, denaturation with different extent and necrosis of renal tubular epithelial cells were observed. Simultaneously, interstitial congestion, edema and infiltration of inflammatory cells were also observed. However, in the TMP-treated group, the outward appearance of the liver and kidney was similar to that of normal. Hepatic cells and tubular cells showed less swelling and no denaturation or necrosis, and interstitial changes were not obvious.
Hepatic and renal function evaluation
Twenty four hours after hepatic reperfusion, the serum levels of ALT (628 ± 91 u/L) and AST (1608 ± 199 u/L) in the saline-treated group were much higher than those in the sham-operated group (52 ± 11 u/L and 80 ± 17 u/L respectively, P < 0.01). The TMP-treated group revealed significantly lower levels of ALT (190 ± 21 u/L) and AST (386 ± 62 u/L) than those in the saline-treated group (P < 0.01).
Twenty four hours after renal reperfusion, the serum levels of BUN (14.54 ± 0.67 mmol/L) and Cr (102.2 ± 4.67 μmol/L) were much higher in the TMP-treated group than those in the sham-operated group (7.88 ± 0.57 mmol/L and 39.00 ± 4.47 μmol/L, respectively, P < 0.01). The TMP-treated group presented with significantly lower levels of BUN (11.21 ± 0.56 mmol/L) and Cr (70.61 ± 4.95 μmol/L) than those in the saline-treated group (P < 0.01).
P-selectin expression in hepatic and renal tissues
P-selectin was expressed widely within hepatic and renal tissues 1 hour after reperfusion, which was mainly distributed on small vessels of left hepatic lobe and kidney. In addition, it was also expressed on part of hepatic cellular membrane, glomerulomesangium, capillary loops, and interstitium. After treatment with TMP, there were no obvious yellow-brown positive granules in the hepatic and renal tissues, suggesting that P-selectin expression was not displayed.
DISCUSSION
Recently, the role of cell adhesion molecules and neutrophils in ischemia and reperfusion injury has aroused attention[29-50]. Ischemia reperfusion liver injury is characterized by microvascular leukocyte accumulation and massive infiltration of postischemic tissues. Primary leukocyte endothelial cell interaction(rolling) is mediated by selectins, whereas firm adherence and transendothelial migration involve immunoglobulin superfamily(intercellular adhesion molecule-1, ICAM-1) with leukocyte β2-integrins (CD11/CD18)[51]. As a potential member of the selectin family, P-selectin has been found in both Weibel-Palade body of epithelial cells of middle and small blood vessels and α-granule of platelets. It is expressed rapidly on the surface of these cells in seconds after their activation. Furthermore, P-selectin can be up-regulated by de novo synthesis in the ischemia-reperfusion injury in hours. P-selectin plays an important role in inflammation by initiating neutrophil rolling, adhesion and recruitment to injured tissue[15]. Blockade of P-selectin expression or interaction with its ligands can attenuate leukocyte adherence and infiltration during ischemia and reperfusion injury. And P-selectin monoclonal antibody has been found to have protective effects on the injury[21].
Tetramethylpyrazine (TMP) is an active ingredient of Ligustium Wallich Franch. It has been shown in animal models and clinical investigations that TMP is effective on ischemic diseases such as heart, brain and lung. TMP could block the calcium channel, reduce the bioactivity of platelets and platelet aggregation, and inhibit free radicals, and has inhibitory roles in platelets and arterial thrombus formation in dogs[52]. However, the roles and mechanisms of TMP in treatment of digestive diseases have not been extensively studied.
The effect of TMP on ischemia and reperfusion injury was observed in this study based on the established rat model of hepatic/renal ischemia-reperfusion.
Hepatic and renal tissues displayed significantly histopathologic damages after hepatic/renal ischemia-reperfusion while the serum levels of ALT and AST as well as BUN and Cr were increased. It was showed that hepatic/renal injury induced by ischemia-reperfusion was remarkably attenuated when TMP was given 5 min before reperfusion as shown by improved hepatic/renal function and less pathologic damage. The results suggest that TMP has a protective effect on hepatic/renal reperfusion injury by inhibiting the interaction of neutrophils and endothelium.
After ischemia and reperfusion, P-selectin expression was up-regulated in hepatic and renal tissues, suggesting that P-selectin is related to hepatic/renal reperfusion injury. It was found that leukocyte rolling and recruitment were delayed when deficient mice are infected, suggesting that P-selectin is involved in the early events of inflammation mediated by leukocytes[53]. Results from this study showed that P-selectin expression in hepatic and renal tissues was inhibited in TMP-treated group. This is consistent with down-regulated expression of sialyl Lewis X, a ligand for P-selectin located mainly in neutrophils, as with anti-P-selectin therapy (unpublished data). These suggest that P-selectin might mediate neutrophil infiltration within the liver and kidney in the early stage of hepatic/renal reperfusion injury. Furthermore, blockade of P-selectin can attenuate inflammatory cell infiltration and pathological damage. Wu found that TMP could reduce significantly the number of α-granule membrane protein(GMP140) of platelets and had inhibitory effects on platelets and arterial thrombus formation in dogs. TMP can play a protective role in hepatic and renal injury caused by ischemia-reperfusion by inhibiting the adhesion and activation of neutrophils mediated by P-selectin.
In an animal model of thioacetamide (TAA) induced acute hepatotoxicity, increase of serum SGOT and SGPT produced by TAA was decreased by TMP, and increase of malondialdehyde (MDA) produced by TAA was also prevented by in vitro addition of TMP to liver homogenates. A rise of serum interleukin-2 was similarly prevented. The results suggest that part of hepatocellular injury induced by TAA is mediated by oxidative stress caused by the action of cytokines through lipid peroxidation, TMP may act by preventing lipid peroxidation[54]. Another study showed that the hepatoprotective effect of TMP might be in part due to its inhibitory ability on membrane lipid peroxidation and free radical formation and its free radical scavenging ability[55]. Therefore, TMP might be effective on the treatment of on reperfusion injury.
Footnotes
Supported by the National Natural Science Foundation of China (No.39970340) and the Scientific Foundation of Ministry of Public Health
Edited by Xu XQ and Wang XL
References
- 1.Funaki H, Shimizu K, Harada S, Tsuyama H, Fushida S, Tani T, Miwa K. Essential role for nuclear factor kappaB in ischemic preconditioning for ischemia-reperfusion injury of the mouse liver. Transplantation. 2002;74:551–556. doi: 10.1097/00007890-200208270-00021. [DOI] [PubMed] [Google Scholar]
- 2.Khandoga A, Biberthaler P, Enders G, Axmann S, Hutter J, Messmer K, Krombach F. Platelet adhesion mediated by fibrinogen-intercelllular adhesion molecule-1 binding induces tissue injury in the postischemic liver in vivo. Transplantation. 2002;74:681–688. doi: 10.1097/00007890-200209150-00016. [DOI] [PubMed] [Google Scholar]
- 3.Satoh S, Suzuki A, Asari Y, Sato M, Kojima N, Sato T, Tsuchiya N, Sato K, Senoo H, Kato T. Glomerular endothelium exhibits enhanced expression of costimulatory adhesion molecules, CD80 and CD86, by warm ischemia/reperfusion injury in rats. Lab Invest. 2002;82:1209–1217. doi: 10.1097/01.lab.0000029620.13097.19. [DOI] [PubMed] [Google Scholar]
- 4.de Rossi LW, Horn NA, Buhre W, Gass F, Hutschenreuter G, Rossaint R. The effect of isoflurane on neutrophil selectin and beta(2)-integrin activation in vitro. Anesth Analg. 2002;95:583–587, table of contents. doi: 10.1097/00000539-200209000-00017. [DOI] [PubMed] [Google Scholar]
- 5.Burne MJ, Rabb H. Pathophysiological contributions of fucosyltransferases in renal ischemia reperfusion injury. J Immunol. 2002;169:2648–2652. doi: 10.4049/jimmunol.169.5.2648. [DOI] [PubMed] [Google Scholar]
- 6.Faure JP, Hauet T, Han Z, Goujon JM, Petit I, Mauco G, Eugene M, Carretier M, Papadopoulos V. Polyethylene glycol reduces early and long-term cold ischemia-reperfusion and renal medulla injury. J Pharmacol Exp Ther. 2002;302:861–870. doi: 10.1124/jpet.102.033688. [DOI] [PubMed] [Google Scholar]
- 7.Khandoga A, Enders G, Biberthaler P, Krombach F. Poly(ADP-ribose) polymerase triggers the microvascular mechanisms of hepatic ischemia-reperfusion injury. Am J Physiol Gastrointest. Liver Physiol. 2002;283:G553–G560. doi: 10.1152/ajpgi.00085.2002. [DOI] [PubMed] [Google Scholar]
- 8.Horie Y, Yamagishi Y, Kato S, Kajihara M, Tamai H, Granger DN, Ishii H. Role of ICAM-1 in chronic ethanol consumption-enhanced liver injury after gut ischemia-reperfusion in rats. Am J Physiol Gastrointest. Liver Physiol. 2002;283:G537–G543. doi: 10.1152/ajpgi.00098.2002. [DOI] [PubMed] [Google Scholar]
- 9.Olanders K, Sun Z, Börjesson A, Dib M, Andersson E, Lasson A, Ohlsson T, Andersson R. The effect of intestinal ischemia and reperfusion injury on ICAM-1 expression, endothelial barrier function, neutrophil tissue influx, and protease inhibitor levels in rats. Shock. 2002;18:86–92. doi: 10.1097/00024382-200207000-00016. [DOI] [PubMed] [Google Scholar]
- 10.Kubes P, Payne D, Woodman RC. Molecular mechanisms of leukocyte recruitment in postischemic liver microcirculation. Am J Physiol Gastrointest. Liver Physiol. 2002;283:G139–G147. doi: 10.1152/ajpgi.00058.2002. [DOI] [PubMed] [Google Scholar]
- 11.Leonard MO, Hannan K, Burne MJ, Lappin DW, Doran P, Coleman P, Stenson C, Taylor CT, Daniels F, Godson C, et al. 15-Epi-16-(para-fluorophenoxy)-lipoxin A(4)-methyl ester, a synthetic analogue of 15-epi-lipoxin A(4), is protective in experimental ischemic acute renal failure. J Am Soc Nephrol. 2002;13:1657–1662. doi: 10.1097/01.asn.0000015795.74094.91. [DOI] [PubMed] [Google Scholar]
- 12.Farmer DG, Amersi F, Shen XD, Gao F, Anselmo D, Ma J, Dry S, McDiarmid SV, Shaw G, Busuttil RW, et al. Improved survival through the reduction of ischemia-reperfusion injury after rat intestinal transplantation using selective P-selectin blockade with P-selectin glycoprotein ligand-Ig. Transplant Proc. 2002;34:985. doi: 10.1016/s0041-1345(02)02730-6. [DOI] [PubMed] [Google Scholar]
- 13.Oktar BK, Gülpinar MA, Bozkurt A, Ghandour S, Cetinel S, Moini H, Yeğen BC, Bilsel S, Granger DN, Kurtel H. Endothelin receptor blockers reduce I/R-induced intestinal mucosal injury: role of blood flow. Am J Physiol Gastrointest. Liver Physiol. 2002;282:G647–G655. doi: 10.1152/ajpgi.2002.282.4.G647. [DOI] [PubMed] [Google Scholar]
- 14.Kuzu MA, Köksoy C, Kuzu I, Gürhan I, Ergün H, Demirpence E. Role of integrins and intracellular adhesion molecule-1 in lung injury after intestinal ischemia-reperfusion. Am J Surg. 2002;183:70–74. doi: 10.1016/s0002-9610(01)00846-7. [DOI] [PubMed] [Google Scholar]
- 15.Zhou T, Li X, Wu P, Zhang D, Zhang M, Chen N, Dong D. Effect of anti-P-selectin monoclonal antibody on renal ischemia/reperfusion injury in rats. Chin Med J ( Engl) 2000;113:790–793. [PubMed] [Google Scholar]
- 16.Stepkowski SM, Chen W, Bennett CF, Condon TP, Stecker K, Tian L, Kahan BD. Phosphorothioate/methoxyethyl-modified ICAM-1 antisense oligonucleotides improves prevention of ischemic/reperfusion injury. Transplant Proc. 2001;33:3705–3706. doi: 10.1016/s0041-1345(01)02511-8. [DOI] [PubMed] [Google Scholar]
- 17.Deng J, Kohda Y, Chiao H, Wang Y, Hu X, Hewitt SM, Miyaji T, McLeroy P, Nibhanupudy B, Li S, et al. Interleukin-10 inhibits ischemic and cisplatin-induced acute renal injury. Kidney Int. 2001;60:2118–2128. doi: 10.1046/j.1523-1755.2001.00043.x. [DOI] [PubMed] [Google Scholar]
- 18.Redlin M, Werner J, Habazettl H, Griethe W, Kuppe H, Pries AR. Cariporide (HOE 642) attenuates leukocyte activation in ischemia and reperfusion. Anesth Analg. 2001;93:1472–1479, table of contents. doi: 10.1097/00000539-200112000-00024. [DOI] [PubMed] [Google Scholar]
- 19.Salter JW, Krieglstein CF, Issekutz AC, Granger DN. Platelets modulate ischemia/reperfusion-induced leukocyte recruitment in the mesenteric circulation. Am J Physiol Gastrointest. Liver Physiol. 2001;281:G1432–G1439. doi: 10.1152/ajpgi.2001.281.6.G1432. [DOI] [PubMed] [Google Scholar]
- 20.Lindner JR, Song J, Christiansen J, Klibanov AL, Xu F, Ley K. Ultrasound assessment of inflammation and renal tissue injury with microbubbles targeted to P-selectin. Circulation. 2001;104:2107–2112. doi: 10.1161/hc4201.097061. [DOI] [PubMed] [Google Scholar]
- 21.Wu P, Li X, Zhou T, Zhang MJ, Chen JL, Wang WM, Chen N, Dong DC. Role of P-selectin and anti-P-selectin monoclonal antibody in apoptosis during hepatic/renal ischemia reperfusion injury. World J Gastroenterol. 2000;6:244–247. doi: 10.3748/wjg.v6.i2.244. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Kojima N, Sato M, Suzuki A, Sato T, Satoh S, Kato T, Senoo H. Enhanced expression of B7-1, B7-2, and intercellular adhesion molecule 1 in sinusoidal endothelial cells by warm ischemia/reperfusion injury in rat liver. Hepatology. 2001;34:751–757. doi: 10.1053/jhep.2001.27804. [DOI] [PubMed] [Google Scholar]
- 23.Weigand MA, Plachky J, Thies JC, Spies-Martin D, Otto G, Martin E, Bardenheuer HJ. N-acetylcysteine attenuates the increase in alpha-glutathione S-transferase and circulating ICAM-1 and VCAM-1 after reperfusion in humans undergoing liver transplantation. Transplantation. 2001;72:694–698. doi: 10.1097/00007890-200108270-00023. [DOI] [PubMed] [Google Scholar]
- 24.Huang X, Ren P, Wen AD, Wang LL, Zhang L, Gao F. Pharmacokinetics of traditional Chinese syndrome and recipe: a hypothesis and its verification (I) World J Gastroenterol. 2000;6:384–391. doi: 10.3748/wjg.v6.i3.384. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Zhou S, Shao W, Zhang W. [Clinical study of Astragalus injection plus ligustrazine in protecting myocardial ischemia reperfusion injury] Zhongguo Zhongxiyi Jiehe Zazhi. 2000;20:504–507. [PubMed] [Google Scholar]
- 26.Liu CF, Lin CC, Ng LT, Lin SC. Protection by tetramethylpyrazine in acute absolute ethanol-induced gastric lesions. J Biomed Sci. 2002;9:395–400. doi: 10.1007/BF02256532. [DOI] [PubMed] [Google Scholar]
- 27.Liu CF, Lin MH, Lin CC, Chang HW, Lin SC. Protective effect of tetramethylpyrazine on absolute ethanol-induced renal toxicity in mice. J Biomed Sci. 2002;9:299–302. doi: 10.1007/BF02256584. [DOI] [PubMed] [Google Scholar]
- 28.Li M, Handa S, Ikeda Y, Goto S. Specific inhibiting characteristics of tetramethylpyrazine, one of the active ingredients of the Chinese herbal medicine 'Chuanxiong, ' on platelet thrombus formation under high shear rates. Thromb Res. 2001;104:15–28. doi: 10.1016/s0049-3848(01)00343-7. [DOI] [PubMed] [Google Scholar]
- 29.Dragun D, Hoff U, Park JK, Qun Y, Schneider W, Luft FC, Haller H. Prolonged cold preservation augments vascular injury independent of renal transplant immunogenicity and function. Kidney Int. 2001;60:1173–1181. doi: 10.1046/j.1523-1755.2001.0600031173.x. [DOI] [PubMed] [Google Scholar]
- 30.Young CS, Palma JM, Mosher BD, Harkema J, Naylor DF, Dean RE, Crockett E. Hepatic ischemia/reperfusion injury in P-selectin and intercellular adhesion molecule-1 double-mutant mice. Am Surg. 2001;67:737–744. [PubMed] [Google Scholar]
- 31.Yabe Y, Kobayashi N, Nishihashi T, Takahashi R, Nishikawa M, Takakura Y, Hashida M. Prevention of neutrophil-mediated hepatic ischemia/reperfusion injury by superoxide dismutase and catalase derivatives. J Pharmacol Exp Ther. 2001;298:894–899. [PubMed] [Google Scholar]
- 32.Maroszyńska I, Fiedor P. Leukocytes and endothelium interaction as rate limiting step in the inflammatory response and a key factor in the ischemia-reperfusion injury. Ann Transplant. 2000;5:5–11. [PubMed] [Google Scholar]
- 33.Laskowski I, Pratschke J, Wilhelm MJ, Gasser M, Tilney NL. Molecular and cellular events associated with ischemia/reperfusion injury. Ann Transplant. 2000;5:29–35. [PubMed] [Google Scholar]
- 34.Burne MJ, Elghandour A, Haq M, Saba SR, Norman J, Condon T, Bennett F, Rabb H. IL-1 and TNF independent pathways mediate ICAM-1/VCAM-1 up-regulation in ischemia reperfusion injury. J Leukoc Biol. 2001;70:192–198. [PubMed] [Google Scholar]
- 35.Fuller TF, Sattler B, Binder L, Vetterlein F, Ringe B, Lorf T. Reduction of severe ischemia/reperfusion injury in rat kidney grafts by a soluble P-selectin glycoprotein ligand. Transplantation. 2001;72:216–222. doi: 10.1097/00007890-200107270-00008. [DOI] [PubMed] [Google Scholar]
- 36.Oe S, Hiros T, Fujii H, Yasuchika K, Nishio T, Iimuro Y, Morimoto T, Nagao M, Yamaoka Y. Continuous intravenous infusion of deleted form of hepatocyte growth factor attenuates hepatic ischemia-reperfusion injury in rats. J Hepatol. 2001;34:832–839. doi: 10.1016/s0168-8278(01)00030-7. [DOI] [PubMed] [Google Scholar]
- 37.Kobayashi A, Imamura H, Isobe M, Matsuyama Y, Soeda J, Matsunaga K, Kawasaki S. Mac-1 (CD11b/CD18) and intercellular adhesion molecule-1 in ischemia-reperfusion injury of rat liver. Am J Physiol Gastrointest. Liver Physiol. 2001;281:G577–G585. doi: 10.1152/ajpgi.2001.281.2.G577. [DOI] [PubMed] [Google Scholar]
- 38.Cabrera PV, Blanco G, Argibay P, Hajos SE. [Isoforms modulation of CD44 adhesion molecule in a murine model of ischemia and intestinal reperfusion]. Medicina ( B Aires) 2000;60:940–946. [PubMed] [Google Scholar]
- 39.Serracino-Inglott F, Habib NA, Mathie RT. Hepatic ischemia-reperfusion injury. Am J Surg. 2001;181:160–166. doi: 10.1016/s0002-9610(00)00573-0. [DOI] [PubMed] [Google Scholar]
- 40.Taut FJ, Schmidt H, Zapletal CM, Thies JC, Grube C, Motsch J, Klar E, Martin E. N-acetylcysteine induces shedding of selectins from liver and intestine during orthotopic liver transplantation. Clin Exp Immunol. 2001;124:337–341. doi: 10.1046/j.1365-2249.2001.01531.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Bojakowski K, Abramczyk P, Bojakowska M, Zwolińska A, Przybylski J, Gaciong Z. Fucoidan improves the renal blood flow in the early stage of renal ischemia/reperfusion injury in the rat. J Physiol Pharmacol. 2001;52:137–143. [PubMed] [Google Scholar]
- 42.Opal SM, Sypek JP, Keith JC, Schaub RG, Palardy JE, Parejo NA. Evaluation of the safety of recombinant P-selectin glycoprotein ligand-immunoglobulin G fusion protein in experimental models of localized and systemic infection. Shock. 2001;15:285–290. doi: 10.1097/00024382-200115040-00006. [DOI] [PubMed] [Google Scholar]
- 43.Zingarelli B, Yang Z, Hake PW, Denenberg A, Wong HR. Absence of endogenous interleukin 10 enhances early stress response during post-ischaemic injury in mice intestine. Gut. 2001;48:610–622. doi: 10.1136/gut.48.5.610. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Rivera-Chavez FA, Toledo-Pereyra LH, Martinez-Mier G, Nora DT, Harkema J, Bachulis BL, Dean RE. L-selectin blockade and liver function in rats after uncontrolled hemorrhagic shock. J Invest Surg. 2001;14:7–12. doi: 10.1080/089419301750072167. [DOI] [PubMed] [Google Scholar]
- 45.Chen W, Bennett CF, Condon TP, Stecker K, Tian L, Kahan BD, Stepkowski SM. Methoxyethyl modification of phosphorothioate ICAM-1 antisense oligonucleotides improves prevention of ischemic/reperfusion injury. Transplant Proc. 2001;33:854. doi: 10.1016/s0041-1345(00)02803-7. [DOI] [PubMed] [Google Scholar]
- 46.Ghobrial R, Amersi F, Stecker K, Kato H, Melinek J, Singer J, Mhoyan A, Busuttil RW, Kupiec-Weglinski JW, Stepkowski SM. Amelioration of hepatic ischemia/reperfusion injury with intercellular adhesion molecule-1 antisense oligodeoxynucleotides. Transplant Proc. 2001;33:538. doi: 10.1016/s0041-1345(00)02130-8. [DOI] [PubMed] [Google Scholar]
- 47.Köksoy C, Kuzu MA, Kuzu I, Ergün H, Gürhan I. Role of tumour necrosis factor in lung injury caused by intestinal ischaemia-reperfusion. Br J Surg. 2001;88:464–468. doi: 10.1046/j.1365-2168.2001.01737.x. [DOI] [PubMed] [Google Scholar]
- 48.Sun Z, Wang X, Lasson A, Böjesson A, Annborn M, Andersson R. Effects of inhibition of PAF, ICAM-1 and PECAM-1 on gut barrier failure caused by intestinal ischemia and reperfusion. Scand J Gastroenterol. 2001;36:55–65. doi: 10.1080/00365520150218066. [DOI] [PubMed] [Google Scholar]
- 49.Amersi F, Dulkanchainun T, Nelson SK, Farmer DG, Kato H, Zaky J, Melinek J, Shaw GD, Kupiec-Weglinski JW, Horwitz LD, et al. A novel iron chelator in combination with a P-selectin antagonist prevents ischemia/reperfusion injury in a rat liver model. Transplantation. 2001;71:112–118. doi: 10.1097/00007890-200101150-00018. [DOI] [PubMed] [Google Scholar]
- 50.Wada K, Montalto MC, Stahl GL. Inhibition of complement C5 reduces local and remote organ injury after intestinal ischemia/reperfusion in the rat. Gastroenterology. 2001;120:126–133. doi: 10.1053/gast.2001.20873. [DOI] [PubMed] [Google Scholar]
- 51.Chen JL, Zhou T, Chu YD, Xu HM, Li X, Zhang MJ, Zhang DH, Wu YL. Study on intercellular adhesion-1 and P-selectin in liver ischemia and reperfusion injury. J SSMU. 1998;10:63–65. [Google Scholar]
- 52.Zou LY, Hao XM, Zhang GQ, Zhang M, Guo JH, Liu TF. Effect of tetramethyl pyrazine on L-type calcium channel in rat ventricular myocytes. Can J Physiol Pharmacol. 2001;79:621–626. [PubMed] [Google Scholar]
- 53.Frenette PS, Mayadas TN, Rayburn H, Hynes RO, Wagner DD. Susceptibility to infection and altered hematopoiesis in mice deficient in both P- and E-selectins. Cell. 1996;84:563–574. doi: 10.1016/s0092-8674(00)81032-6. [DOI] [PubMed] [Google Scholar]
- 54.So EC, Wong KL, Huang TC, Tasi SC, Liu CF. Tetramethylpyrazine protects mice against thioacetamide-induced acute hepatotoxicity. J Biomed Sci. 2002;9:410–414. doi: 10.1007/BF02256534. [DOI] [PubMed] [Google Scholar]
- 55.Liu CF, Lin CC, Ng LT, Lin SC. Hepatoprotective and therapeutic effects of tetramethylpyrazine on acute econazole-induced liver injury. Planta Med. 2002;68:510–514. doi: 10.1055/s-2002-32569. [DOI] [PubMed] [Google Scholar]